MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Consolidator ... Mass Market Scale-up, Global Reach, Public Capital
2) Consolidators: Medical Device Sector
Consolidators: Laboratory Equipment, Testing, Information Systems, Reagents & Assays
QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA)
Organization & Developments: Qiagen
Parents
QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA)
Children
*A Netherlands holding company
*Assay technologies are used to make such isolated bio-molecules visible.
*Consolidated under the Dutch holding QIAGEN N.V., the company operates more than 35 offices in over 25 countries.
*Frankfurt Prime Standard: QIA)
*Leading global provider of sample and assay technologies.
*Maker of genetic testing equipment,
*QIAGEN has developed and markets more than 500 sample and assay products as well as automated solutions for such consumables.
*QIAGEN is a provider of sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research.
*Qiagen N.V.: Organization
*QIAGEN's ESE fluorescence-based optical technology
*QIAGEN's North American headquarters based in Germantown and Gaithersburg, Maryland
*Sample technologies are used to isolate and process DNA, RNA and proteins from biological samples such as blood or tissue.
*The company provides its products to molecular diagnostics laboratories, academic researchers, pharmaceutical and biotechnology companies, and applied testing customers for purposes such as forensics, animal or food testing and pharmaceutical process contr
2012: QIAGEN Teams with China's Lepu Medical to Provide Rapid Diagnosis of Heart Attacks Using Point of Need Testing (2012)
2014: QIAGEN Adds Promising New Biomarker to Pipeline of Personalized Healthcare Assays to Improve Diagnosis of Blood Disorders
2014: Qiagen launches new features for bioinformatics solutions
2016: USAMRIID to issue a sole source award for software to Qiagen Software
2017: CDC_Maintenance Agreement
2017: CDC_QIAGEN EZ1 Advanced XL
2017: NIH_Qiagen Laboratory equipment and supplies and service agreement, no PM
2017: NIH_Qiagen, Human Gene Mutation Database Access
2017: Qiagen Partners with Cell Diagnostics Company, ANGLE plc, a liquid biopsy company
2017: U.S. Air Force_Qiagen MicroRNA Sequencing Supplies
2018: NIH_Human Gene Mutation Database Access
2018: NIH_IPA Software from Qiagen
2018: U.S. Army_Qiagen Sole Source_Supplies for Cloud Genomics Software and Maintenance
2019: Genetic Testing Companies Take DNA Tests To A Whole New Level
2019: Illumina and Qiagen ink long-term IVD diagnostics partnership_seekingalpha.com
2019: U.S. Army_USAMRMC_Network License and maintenance and Support
2020: Qiagen joins with T-cell biotech TScan to develop immune system test for COVID-19
2021: QIAGEN Receives U.S. FDA Emergency Use Authorization for Fast and Easy-to-Use Digital Test to Detect SARS-CoV-2 Coronavirus Antibodies_Qiagen N.V.
2023: QIAGEN and Helix Launch Exclusive Partnership to Advance Next-Generation Sequencing Companion Diagnostics in Hereditary Diseases_seekingalpha.com
2023: Qiagen Q1 Revenues Fall 23 Percent but Exceed Outlook, Analyst Estimates
2024: Qiagen N.V. 2023 Q4 - Results - Earnings Call Presentation
2025: Qiagen Beats Earnings, But Its Expensive Valuation Caps Upside Potential
2025: Qiagen: Diagnostics Vs. Life Sciences Pair Trade Analysis
Jumps
*Key People: Qiagen
Finance & Acquisitions: Qiagen